Major pathogenicity inducing pathways/responses in Candida species.
Abstract
In normal human microbiome, the polymorphic fungus Candida albicans is a crucial member. C. albicans resides mostly in individual as harmless commensal life. In specific situations, however, C. albicans can cause diseases that cause contaminations of the skin to life-threatening fundamental contaminations. Pathogenesis of Candida species is contributed by multiple factors. Some of the major contributors are enlisted here. These include host pathogen interaction, receptors molecule like TLR recognition, TLR signaling, C type lectin receptors, Dectin 1,2 and 3, mannose receptor, mincle, DC sign, Nod-Like Receptors (NLRs) and inflammasomes, soluble molecules in candida recognition, cellular responses to candida such as neutrophils, macrophages. This chapter enlightens all the components of candida pathogenicity by the assessment of Candida species pathogenic determinants. All together these will explain the current knowledge about how these determinant factors and receptors modulate virulence as well as consequent infection. Better understanding of candida pathogenicity mechanism can be the resultant of better treatment guidelines along with development of novel antifungal agents. Overall, in this review we present an update in the current understanding of the insight of pathogenicity mechanisms in this important human pathogen.
Keywords
- Pathogenicity
- C. albicans
- TLR
- receptor
- lectin
1. Introduction
Candida is a diploid parasite that as often as possible causes mucosal and fundamental contaminations in people [1]. Candida species can colonize a few particular anatomical locales. Greater part of diseases by commensal microorganisms comes from endogenous colonization. Notwithstanding, exogenous pollution, for example, diseases communicated through emergency clinic workers, medical clinic air, and biofilm-debased intrusive gadgets like catheters, can likewise happen [2, 3, 4]. Diseases brought about by Candida can be delegated shallow, cutaneous, mucosal, and fundamental infection. At the point when Candida spp. taint the oral cavity, skin, genitalia, respiratory framework, and the remainder of the gastrointestinal lot, the disease is delegated the shallow sort. Intrusive candidiasis is a disease portrayed with very extreme conditions, for example, candidemia, meningitis (influencing the mind), and endocarditis (influencing the heart) [5]. In hospitalized patients and those with bedraggled safe framework, intrusive contamination is a huge reason for dismalness and mortality along with increased frequency as well as pervasiveness rates.
Candida species pathogenesis is a complex cycle including numerous instruments and pathways. It is likewise a mind boggling and multifactorial system, including highlights of both the host and the microorganism [6]. For contamination to be set up, the pioneering microorganism should avoid, duplicate in the host climate, and make do in the safe arrangement of the host. The living being must likewise have the option to scatter to other body tissues and organs, most particularly in foundational disease [7]. Problem in skin or gastrointestinal boundaries can prompt dispersed or profound organ candidiasis. In more significant circumstances, circulatory system intrusion may some time possible which hence will disperse to various organs of the body.
Candida contaminations in a great many people are asymptomatic. This is because of the capacity of the immunological framework to checkmate the life form as it endeavors to spread in the body. In any case, consumption in resistant systemor changes in microbiota balance, combined with different elements, can work with the spread of Candida which is regularly deadly in 42% of announced cases [8, 9, 10].
As anyone might expect, it is the destructiveness and pathogenic qualities and components that have gotten the most consideration from specialists throughout the long term. As of late, much have been found out about the components of Candida pathogenesis. Studies have shown that at the core of the capacity of Candida to multiply, change from non-destructiveness commensal to pioneering pathogenic organism and build up disease in the host lie profoundly interconnected elements made out of transcriptional circuits, morphology-related/harmfulness encoding qualities, metabolic versatility, genome pliancy, phenotypic exchanging, biofilm arrangement, tissue harming extracellular hydrolytic catalysts, and a few different variables that work with destructiveness and pathogenesis in Candida species [15]. Changes in ecological pH, vigorous supplement procurement framework, escape from phagocytosis, avoidance from have insusceptible framework, have microbiome coaggregation, protection from antifungal specialists, and the capacity to productively react to numerous anxieties are other crucial characteristics that upgrade endurance and pathogenesis.
In order to be capable of inducing such a diversity of infections
2. Pathogenicity mechanism of Candida species
2.1 Infection
The pathogenicity of
S/no. | Pathways | Functions | Reference(s) |
---|---|---|---|
1 | Mitogen-activated protein kinase (MAPK) pathways | Important regulator of morphogenesis. | [22, 23] |
Involved in sensing and transmitting stress signals and other environmental signals | |||
Three main MAP kinase pathways are the following:
| [24]. | ||
2 | Ras-CAMP-PKA pathways | Regulate adhesion, dimorphism. Also involved in the formation of biofilms. | [23, 25, 26] |
Control hyphal formation and white-to-opaque change | [27, 28] | ||
Involved in drug tolerance and in the maintenance of cell wall integrity | |||
3 | RIM 101 signal transduction | Enables | [29] |
4 | Stress response pathways | Contribute to virulence and pathogenesis Facilitate adaptation to ever-changing environmental conditions. Protect against host-derived stresses | [30] |
5 | Ergosterol biosynthetic pathways | Link between hyphae formation and virulence in | [31] |
Enhance cell adhesion and damage to the tissues | [32] | ||
ERG3 and ERG11 play major roles in azole drug resistance; thus, it is the target of fluconazoleantifungals | |||
6 | Genome plasticity | Triggers adaptation to fluctuating host environment. Leads to the generation of recombinant progeny with increased fitness. Induces natural mutations that alter the balance between commensalism and pathogenicity. | [33, 34] |
Facilitates resistance to stressors including antifungal agents and pathogenicity during systemic and mucosal infections | [35] | ||
Triggers polarized filamentous growth Involved in the generation/evolution of new pathotypes or strains Enhances the utilization of several nutrients. Facilitates Candida growth rate, as well as its morphology and behaviors at the host interface | |||
7 | Calcium-calcineurin pathways | Major mediator of stress responses | [36] |
Essential for survival in the presence of stressors | [37] | ||
Play crucial roles in virulence | [38, 39] |
Table 1.
The greater part of the flagging pathways are amazingly fundamental for protecting Candida spp. against immunological assault [40]. They assume different parts in the declaration of morphology related qualities. The co-articulation of morphology-connected proteins brings about synergistic association among quality items fundamental for biofilm foundation and development inside the host [41]. Along these lines, for hindering Candida endurance in have tissues, impedance with Candida species capacity to incorporate quality articulation to changes in morphology could be surely a potential restorative technique [42]. Also, distinguishing flagging segments saved among Candida species is vital for recognizing potential medication targets. During the interaction of pathogenesis, actuated endocytosis happens. It for the most part happens inside 4 h of starting contact to epithelial cell. Candida uses prompted endocytosis to sidestep invulnerable acknowledgment. The acknowledgment of invasins communicated on the contagious cell surface triggers prompted endocytosis. Until this point, only A1s3p and Ssa1p (invasins) are known for
Adhesion to the cellular epithelium.
Colonization.
Penetration to epithelium/hyphal invasion.
Dissemination of vasculature.
Endothelial colonization/penetration.
Systemic candida infection only occurs by immune system escape than vasculature penetration and invading the blood components. Entry to the bloodstream occurs via two routes:
Natural routes.
Artificial routes.
Above subsequent course is worked with biofilm arrangement as pathogens can get away and invade the blood. For Candida to endure and spread in the blood, various qualities are upregulated: qualities engaged with protein amalgamation, glycolytic cycle, glycolysis, and reaction to oxidative pressure. The presence of Candida in the blood prompts a condition called candidemia. From the blood, the yeast is dispersed to different fundamental organs in the body where it causes foundational contaminations. Dispersed candidiasis is profoundly worked with by extracellular hydrolytic compounds, adhesins, phenotypic exchanging, and cytolytic proteins. Candida in the blood can likewise bring about candiduria by antegrade contamination. Albeit most diseases include biofilm arrangement, a few contaminations can happen without the development of biofilm. Indeed, hyphae development and development are the beginning stages in the pathogenicity of Candida species, with the exception of
Notwithstanding, questions actually remain with respect to the instruments controlling its union, the receptors, and its carrier. In outline, the exchanging of Candida spp. from commensal to artful microbe is ascribed to destructiveness factors that are specifically communicated under reasonable inclining conditions. The majority of these destructiveness factors are under close guideline. More examinations in their administrative instruments could be fundamental in the mission for new antifungal specialists. Figure 1 is the significant organization of Candida destructiveness and pathogenesis showing the associations between the different pathogenic determinants and harmful variables.

Figure 1.
Simplified diagram illustrating the network of Candida virulence and pathogenicity. (1) planktonic yeast cells attach to surfaces. Favorable conditions facilitate overgrowth; adherence (2): The cells attach to host cells via adhesins; hyphae formation/extension (3): Environmental constrains induce the HSPs, signaling and adaptation pathways which induce morphology-associated genes. The formation of the hyphae marks the beginning of Candida pathogenesis. Epithelial/endothelial adhesion/invasion (4 and 6): This is facilitated by hydrolytic enzymes and it is achieved via two ways: Induced endocytosis and active penetration. Some species such as
2.2 Host response to Candida species
Host insusceptible acknowledgment of Candida happens through a few instruments involving intrinsic and versatile insusceptibility. The versatile insusceptible framework perceives explicit antigenic moieties, prompting the advancement of a focused on safe reaction. Interestingly, inborn insusceptible acknowledgment is vague and wide and is the primary line of host protection against possibly hazardous organisms. These vague reactions are promptly endless supply of an organism in a pre-modified design and assume a fundamental part in controlling contagious weights and forestalling infection. Natural invulnerability includes a progression of dissolvable (supplement) and cell (neutrophil, macrophage) parts that act in show to keep by far most of microbes from setting up an intrusive disease. Further, it has become progressively clear that these reactions capacity to enact versatile insusceptibility just as acting along with other homeostatic cycles to give further security. Natural invulnerable acknowledgment of Candida happens through the acknowledgment of microorganism related atomic examples (PAMPs).
PAMPs are themes or particles that are regular between various sorts of growths. In contrast to antigens, individual PAMPs are not explicit to a solitary Candida animal variety but instead are divided among various species and contagious genera. These microbial PAMPs are perceived by have germline encoded design acknowledgment receptors (PRRs) [45] and give a pre-customized method of parasitic acknowledgment, taking into consideration moment acknowledgment of normal contagious parts. Most of contagious PAMPs are cell divider related and incorporate 𝛽-glucans, 𝑁-and 𝑂-connected mannans, and phospholipomannans [46]. These are perceived by three key PRR families: cost like receptors (TLRs), C-type lectin receptors (CLRs), and nucleotide-restricting area leucine-rich receptors (NLRs) [46, 47, 48, 49, 50, 51, 52]. Dendritic cells, monocytes, macrophages, polymorphonuclear leukocytes (PMNs), Tcells, Bcells, and epithelial cells all transmit PRRs on a surface level, in endosomes or in the cytoplasm of host cells. Sanctioning of these PRRs by PAMPs prompts setting off of intracellular hailing pathways, as MAPK (mitogen-started protein kinase) and NF-𝜅B (nuclear factor kappa-light-chain-enhancer of incited B cells) pathways, and finally to further developed record of countless characteristics drew in with have safe protections, including chemokines, cytokines, provocative center individuals, and antimicrobial peptides. Appropriately, PRRs are fundamental center individuals among intrinsic and adaptable safe responses.
3. Receptor molecules in Candida recognition
While comparing the human genome with murine genome; human genome encodes for ten TLR characteristics (TLR1–10) and murine genome encodes 12 i.e. TLR1 to TLR9 and TLR11 to TLR13. Each TLRs depicted as transmembrane type-1receptors having an enriched lucine extracellularly intermittent region which sees target PAMP and a Toll/interleukin-1 receptor-(TIR-) space containing cytoplasmic region that imparts the institution stimuli, which having closeness to the sort 1 interleukin-1 (IL-1) receptor. TLR family is a developmentally monitored gathering of PRRs that react to an assortment of bacterial, viral, and contagious PAMPs just as some endogenous components delivered when have cells are harmed. The extracellular areas of TLRs perceive an assortment of microbial PAMPs, including lipopolysaccharide (LPS), peptidoglycan, proteins (counting triacylated proteins and flagellin), and changed nucleic acids [53, 54, 55, 56, 57, 58].
3.1 Toll like receptors
3.1.1 TLR recognition of Candida
Key part for TLRs in host protection against fungal infection was initially identified when Drosophila inadequate in Toll receptor were seen to profoundly helpless to A. fumigatus disease [59]. Therefore by far most of the underlying antifungal insusceptibility research focused on how contagious cells were perceived. This provoked the distinctive verification of a couple of PRRs related with affirmation of different cell divider polysaccharides of parasites and
At last, these investigations finished in the disclosure of another PRR, dectin-1 (dendritic cell associated C-type lectin-1), who perceives parasitic 𝛽-1,3 glucan [61]. Outstandingly, these parasitic PRRs can work both freely and related to each other. For instance, dectin-1 and TLR2 act additionally to perceive contagious yeasts, with dectin-1 prompting phagocytosis while TLR2 initiates cytokine creation [62, 63, 64]. Dectin-1 likewise synergises with TLR4 flagging [64]. Moreover, TLR1 and TLR6 structure heterodimers with TLR2 [65] however do not seem to assume a significant part in
Even so these are standard receptors utilized by macrophages and neutrophils to see
Curiously, galectin-3 coimmunoprecipitates accompanied by dectin-1 [74], which recommends that galectin-3 can work with associations among TLR2 and dectin-1 flagging. TLR acknowledgment of other medicinally significant growths have likewise been concentrated yet are less very much described, despite the fact that apparently TLR3 perceives A. fumigatus conidia and TLR4 perceives
3.1.2 TLR signaling
PAMP acknowledgment of TLRs brings about enactment of flagging cascade intracellularly (Figure 2) through connection of the cytoplasmic TIR spaces with various connector proteins: myeloid separation essential reaction quality (88) (MyD88), MyD88-connector like (MAL), TIR-area containing connector initiating interferon-𝛽 (TRIF), and TRIF-related connector atom (TRAM) [53, 54, 55, 56, 57, 58, 76, 77, 78, 79]. This TLR-adapter interaction ends up in the activation of the IRAK ( IL-I receptor associated kinase) proteins and TRAF6 (TNF receptor associated factor-6). As a result it ends up in activation of the main signaling pathways together with NF-𝜅B, MAPK, and IRF (interferon regulative factor) pathways. MAPK activation contains 3 alleyways: p38, JNK (c-Jun N-terminal kinase), and ERKI/2 (extracellular signal-regulated kinaseI/2). Finally, signaling pathway induction ends up in the activation and nuclear localisation of transcription factors as well as NF-𝜅B, AP-I (activating macromolecule I), and IRF-3 and IRF-7. the result of this activation cascade is to induce organic phenomenon and secretion of varied proteins concerned in immune defense as well as cytokines, chemokines, antimicrobial peptides, and alternative inflammatory mediators, all of that operate to stimulate innate and reconciling responses of immune system. It thought to be noted that the overwhelming majority of studies shaping the TLR-mediated pathways are performed victimization myeloid or humor cells, however elaborated analysis of TLR- mediated pathways in alternative cell varieties, and specifically animal tissue cells, could nonetheless establish novel and strange mechanisms of infectious agent (fungal) recognition and management at membrane surfaces.

Figure 2.
Signal pathway activation by TLRs and CLRs. TLRs and CLRs activate MAPK and NF-𝜅B signal pathways to varying extents, thereby allowing different innate immune responses to be generated. TLRs utilize TIR-domain containing adapter proteins such as MyD88, mal, TRAM, and TRIF. CLRs signal using ITAM domains within their cytoplasmic region (e.g., dectin-1) or associate with an ITAM-containing transducing protein (e.g., dectin-2 with FcR𝛾). Dectin-1 utilizes Src kinases and Syk kinase to activate a complex containing CARD9, MALT1, and Bcl1o to activate the downstream signal pathways. Figure adapted from [
3.1.3 Role of TLRs during Candida infection
Although animals missing the TLR signaling adaptor protein MyD88 are vulnerable to fungal infection [46, 80, 81, 82], the exact role of particular TLR receptors in fighting Candida infections is unclear. This is most likely because of contrasts in examination plan, where diverse contagious species, morphotypes, and courses of contamination have been surveyed [52]. Thusly, contemplates utilizing TLR knockout mice have uncovered critical contrasts in the putative jobs of various TLRs in fundamental or mucosal insusceptible reactions against contagious contaminations [83]. For instance, while a few examinations demonstrate that TLR2 and TLR4 impact vulnerability to murine scattered candidiasis [82, 84, 85, 86], not all investigations support this attestation [87, 88]. TLR7 might be needed for parasitic RNA acknowledgment in the autophagosome, which is needed for IFN-𝛽 discharge and is related with delayed
A few examinations have related normal hereditary variations (polymorphisms) in TLR qualities with vulnerability or inclination to foundational candidiasis or constant mucocutaneous candidiasis (CMC). These recollect polymorphisms for TLRI (R80T , N248S , and S602I) [94, 95] and TLR3 (L4I2F) [96, 97]. Polymorphisms in TLR4 (D299G) and TLR2 (D753Q) have moreover been perceived as possible frailty markers for basic candidiasis [98] yet these could not be approved in a greater report [95]. As of now, a large portion of the information accessible recommends a solid part for TLRs in antifungal protection however recognizing explicit jobs for each TLR has been over shadowed by repetitive signs instigated by other PRRs [94].
3.2 C-type lectin receptors
CLRs (C-type lectin receptors) are a diverse restriction protein family defined by the presence of an extracellular carb acknowledgment space (CRD) or a C-type lectin like area (CTLD) [99]. The job of CLRs in antifungal insusceptibility has been the subject of serious investigation as of late and a few key CLRs have now been shown to show basic capacities in Candida acknowledgment, take-up, and executing and furthermore add to the commencement and additionally tweak of the resistant reaction to organisms [46, 100, 101]. By and by, the key CTLs in Candida affirmation appear, apparently, to be dectin-I, dectin-2, and MR. CLRs signal through incitation of ITAM/ITIM (immunoreceptor tyrosine-based actuation/restraint theme) cytoplasmic areas (Figure 3). This can be done by using their own cytoplasmic area, as dectin-I does, or by using coreceptor cytoplasmic spaces, as DAPI2 (DNAX actuation protein of I2 kDa) and FcR (Fc receptor gamma chain) do, as dectin-2 does. The activation of numerous connections to those activated by TLRs, most notably Src family kinases including Src, Lyn, and Fyn, is triggered when CLRs are ligated. If we talk about dectin-I , it prompts initiation of spleen tyrosine kinase (SYK) and the downstream actuation of the CARD9/BclI0/MALTI (caspase enlistment space family/B cell CLL-lymphoma I0/mucosa related lymphoid tissue lymphoma movement quality I) flagging complex. Independent of the CLR pathways and connectors utilized, a definitive outcome is the enactment of comparative flagging pathways as those initiated by TLRs, overwhelmingly NF-𝜅B and MAPK, that are discussed below point.

Figure 3.
Signaling and damage pathways activated by C. albicanshyphae. C. albicanshyphal cells, when in sufficient quantities, are recognized by an unknown PRR mechanism that results in the activation of NF-𝜅B, MAPK, and PI3K pathways. MAPK signaling via p38 and ERK1/2 appears to discriminate between yeast and hyphal cells. Activation of p38 by hyphae leads to activation of the c-Fos transcription factor, which, in conjunction with the p65/p50 NF-𝜅B heterodimers and PI3K/AKT results in upregulation of cytokine and inflammatory mediator expression. Concurrently, activation of ERK1/2 signaling, results in stabilization of the MKP1 phosphatase, which deactivates p38 and JNK, hence acting as part of a negative feedback loop and preventing a potentially deleterious overreaction of theimmune system. Damage induced by hyphae appears to be mediated via JNK activation and prevented via the PI3K/AKT/mTor pathway.
3.2.1 Dectin-I
Dectin-I, (also called CLEC7a) is that the main CLR known as taking part in a serious role in fungous recognition by the host system [102] and may be a sort II transmembrane macromolecule that belongs to a subgroup of CLRs referred to as natural killer (NK) receptor-like CLRs. The target ligands of dectin-I are 𝛽-I,3 glucan polymers, that comprise a serious part (∼60%) of fungous cell walls. The intracellular region of dectin-I contains a changed ITAM motif containing one amino acid residue rather than the standard 2 (hence the terms hem-ITAM or hemi- ITAM). Activation of the dectin-I results in phosphorylation of this domain and phosphorylation of SYK and activation of the BclI0- CARD9-MALTI complicated as mentioned on top of. This results in activation of each the canonical and noncanonical NF-𝜅B pathways [103] further as nuclear issue of activated T cells (NFAT) pathway [104]. Dectin-I can even induce signaling via Raf-I in an exceedingly SYK -dependent fashion [103] and is related to phospholipase C and A2 activation [50]. one in all the most important functions of dectin-I binding seems to be the induction of bodily process [105]. However, a singular feature of dectin-I is its ability to be activated or suppressed by its target matter. to completely activate dectin-I, cells got to be exposed to insoluble 𝛽-glucan particles. Notably, exposure of dectin-I to soluble 𝛽-glucan seems to dam activation. This appears to ensue to the apparent form type a vegetative cell conjunction,“whereby phosphatases that usually suppress ITAM motifs are accumulated. This exclusion later permits the phosphorylation of the intracellular hem-ITAM motif [106], thereby sanctioning bodily process. Dectin-I has additionally been shown to synergise with each TLR2 and TLR4, leading to the induction of tumor necrosis factor (TNF), IL-I0, transforming growth factor (TGF) and dendritic cell maturation [107, 108, 109]. In view of the fact that the 𝛽 - I,3 glucan polymers that are the main components of the fungal cell wall, and a strong activation of the immune system, dectin-I plays an important role in inducing antifungal activity of the host. This may also explain why some of the mold surface structure of “the mask” -I.3 glucan from the immune system. For example, Histoplasma capsulatum, masks are 𝛽-I,3 glucan, with a low - 𝛼-I,3 glucan [110] and it seems likely that the
Although some studies have shown that the expression of dectin-I in the epithelial cells of the gastro- intestinal tract [112], and lung [113, 114], in oral epithelial cells express dectin-1 [115, 116]. What’s interesting is that dectin-I expression appears to be reduced in the presence of live
3.2.2 Dectin-2
Dectin-2 (otherwise called CLEC6a) is a sort II transmembrane protein however is enacted contrastingly to dectin-I. Dectin-2 comes up short on an intracellular flagging area [128] and requirements to dimerise with FcR𝛾, which has an intracellular flagging space, to send a sign [69]. In myeloid cells and fiery monocytes, dectin-2 perceives high mannose structures that are normal to numerous parasites and ties to hyphae with higher proclivity than to yeast [129, 130]. This may clarify why dectin-2 inadequate mice are helpless to
3.2.3 Dectin-3
Dectin-3 (additionally called CLECsf8, MCL, or CLEC4d) was as of late distinguished and seems to shape heterodimers with dectin-2 to perceive 𝛼-mannans on the outside of
3.2.4 DC-SIGN
DC-SIGN (otherwise called CD209) is another sort II transmembrane receptor that is communicated dominatingly on dendritic cells and macrophages. Dendritic Cell-Specific Intercellular adhesion molecule-3-Grabbing Non-integrin) also known as CD209 (Cluster of Differentiation 209) is a protein which in humans is encoded by the CD209 gene. DC-SIGN is a C-type lectin receptor present on the surface of both macrophages and dendritic cells Nonetheless, the part of DC-SIGN in antifungal invulnerability is muddled [101], in spite of the fact that DC-SIGN seems to perceive high (𝑁-connected) mannose containing glycoproteins and actuate IL-6 creation [71, 136]. Albeit the part of DC-SIGN in the endocytosis and take-up of microbes to advance antigen show is all around recorded [136, 137], its job in phagocytosis is sketchy [71, 136].
3.3 Mannose receptor
The MR (or called CD206) is a prototypical kind I transmembrane protein that is transcendently communicated on macrophage and dendritic cells. MR receptor ties a few starch particles, including extended 𝑁-connected mannans, N-acetylglucosamine, glucose, and fucose [138]. Thus, MR can perceive numerous contagious, bacterial, and viral pathogens. MR needs regular intracellular flagging spaces despite the fact that ligation actually prompts an assortment of cell reactions, including signal pathway acceptance, phagocytosis, advancement of antigen show to T cells, and cytokine discharge [63, 136, 137, 138, 139, 140]. For instance, the MR is enlisted to the phagosome after
3.4 Nod-like receptors (NLRs) and inflammasomes
NLRs are a group of intracellular PRRs portrayed by leucine rich rehashes and a nucleotide-restricting area that identify PAMPs present in the cell cytoplasm. Like TLRs and CTLs, NLRs perceive microbial items yet they additionally perceive have determined threat signals or alarmins [145]. There are now 23 human NLRs and 34 mouse NLRs identified [146]. Inflammasomes are huge multimeric protein structures framed by NLRs and two distinct proteins, ASC (apoptosis-related spot like protein containing a CARD) and procaspase-I (procysteine-subordinate aspartate-coordinated protease I). The inflammasome’s main function is to convert procaspase-I to dynamic caspase-I, which causes young cells that are friendly to IL-I and supportive of IL- I8 to produce IL-I and IL-I8 [147]. Despite the fact that
Surprisingly, NLRP3 is strongly expressed in nonkeratinizing epithelia, such as the oral cavity and throat [151], suggesting a possible role for NLRP3 in parasitic recognition in oral epithelial cells, which is supported by studies showing increased IL- I and IL- I8 levels in response to
4. Protein involves in pathogenesis
4.1 Mincle
Mincle (also known as CLEC4e or CLECsf9) is a type II transmembrane protein that transmits its signal after dimerizing with the FcR connector protein [128]. Macrophages, monocytes, neutrophils, myeloid dendritic cells, and certain B cell subsets all communicate mincle, while plasmacytoid dendritic cells, T cells, and NK cells do not [133]. Mincle binds -mannans-containing starch structures [143, 163] and detects
4.2 Soluble proteins in Candida recognition
The supplement course assumes a significant part in have protection against parasitic microorganisms and is quickly enacted in light of host attack by Candida [168, 169, 170]. Candida actuates each of the three known pathways (old style, elective, and mannose-restricting lectin (MBL)) with nobody clear pathway overwhelming the reaction [171]. Given that the Candida cell surface is covered with a bounty of manno proteins, it is not astonishing that Candida microorganisms are viable at actuating the MBL pathway, which seems significant for opsonisation, phagocytosis, and other supplement capacities [172, 173]. The connection between enacted C3b and the supplement receptor CR3 is generally needed for the uptake of Candida cells by phagocytes [174].
5. Cellular responses to Candida
5.1 Neutrophils
Neutrophils are a key effector cell in intrinsic insusceptibility, and they play a dual role in antifungal responses. First, they phagocytose and destroy contaminated Candida cells (below), and then, via cross communication with epithelial cells, they indirectly assist in mucosal protection (tended to above). TLRs and CTLs help neutrophils phagocytose nonopsonized Candida, while CR3 and the Fc receptor (FcR) help them phagocytose opsonized Candida [193]. Once phagocytosed, Candida is killed both inside and outside the cell through oxidative and nitrosative mechanisms, but fungicidal movement varies across Candida species [194, 195]. Preformed cytoplasmic granules interweave with the phagosome intracellularly, although unlike macrophages, no substantial pH changes occur [196]. Antimicrobial proteins found in neutrophil granules include defensins, lactoferrin, lysozyme, myeloperoxidase, and elastase [197], all of which can be transported into the extracellular environment. Candida’s phagocytic execution requires oxidative processes. During the oxidative burst, neutrophils create reactive oxygen species (ROS), which needs the NADPH oxidase catalyst complex to assemble in the cytoplasmic and phagosomal film [198]. First, the superoxide extremist is formed, which is subsequently dismutated to hydrogen peroxide, an oxidative and harmful particle [199].
Then, myeloperoxidase uses hydrogen peroxide to create hypochlorous acid, which is moreover an exceptionally oxidative particle that responds with natural amines to frame chloramines that have further antimicrobial stuffs [193, 200]. Candida’s phagocytic execution is further aided by reactive nitrogen species (RNS) [193]. When neutrophils are activated, they produce nitric oxide (NO) from arginine and oxygen via an enzyme called inducible nitric oxide synthase (iNOS). NO is extremely sensitive, and it is converted to peroxynitrite, which is then reduced to nitrogen dioxide and a hydroxyl radical. Because iNOS is restricted to the intracellular compartment, RNS production is restricted to the intracellular compartment [199]. The creation of neutrophil extracellular catches (NETs) [201, 202], which are formed during a unique sequence of neutrophil cell death known as NETosis, is another more recently found way of Candida executing. Similar to serine proteases, antimicrobial peptides (e.g., calprotectin), and other microbicidal chemicals, the neutrophil “explodes,” unleashing a snare of chromatin fibrils coated with the neutrophil’s material. Candida spp. are well-versed in surviving the oxidative, nitrosative, osmotic, and restorative nerves encountered during interactions with neutrophils. Because of the weights, many cycles, features, and proteins are altered within the organism. These include upregulation of transporters (e.g., oligopeptide, ammonium, and iron), use of alternative carbon and nitrogen sources and metabolic cycles (e.g., glycolysis, glyoxylate, unsaturated fat, and amino destructive), and detoxification of neutrophil oxidative/nitrosative butchering instruments. (e.g., catalase, superoxide dismutases, and nitric oxide dioxygenase). In any event, these nuances are beyond the scope of this examination, and the reader is directed to a later examination that focuses on the Candida reaction to neutrophils [193, 203].
5.2 Macrophages
Macrophages can function as phagocytic cells as well as antigen-presenting cells capable of activating T lymphocytes. Upon activation, macrophages divide into two phenotypically and functionally distinct subsets, M1 and M2, based on the cytokine milieu in which they are initiated [204, 205, 206]. The M1 total is derived from receptiveness to the T colleague (Th)1 cytokine IFN, whereas the M2 total is derived from receptiveness to Th2 cytokines, IL-4 and IL- 13. M1 macrophages are microbic and proinflammatory, whereas M2 macrophages are involved in wound healing and extracellular network upgradation. Macrophages, like neutrophils, see and phagocytoze nonopsonised Candida via TLRs and CTLs, and opsonised Candida via CR3 and FcR [193, 207]. Nonetheless, macrophage phagosome formation differs from neutrophil phagosome development in that macrophage phagosomes follow the endocytic development route and grow into phagolysosomes with a distinctive acidic pH that promotes compound activity, such as cathepsin D [208]. M1 macrophages use both oxidative and nitrosative executing components (as seen above for neutrophils), but they also use the RNS, NO, to directly kill phagocytosed Candida via the translocation of iNOS. TNF and the chemokines CXCL9 and CXCL10 are also released by M1 macrophages [209]. These chemokines act as ligands for the CXCR3 receptor, which is found on Th1 cells and NK cells, attracting resistant cells to contamination sites.
M2 macrophages, then again, advance contagious ingenuity inside the macrophage, giving an instrument to invulnerable avoidance. M2 macrophages additionally express more significant levels of MR (CD206) bringing about expanded phagocytosis of Candida [210]. Correspondingly, the arginase-1 (Arg1) quality is additionally expanded in articulation, which rivals iNOS for a similar substrate (arginine), consequently diminishing NO levels [211]. This is additionally exacerbated by decreased degrees of TNF𝛼 creation in M2 macrophages. In light of this, macrophages anticipate playing an important role in Candida protection, but this is contingent on the Candida strain assisting the macrophage [212]. Candida spp., like neutrophils, are believed to rely on relative adaptations to survive in macrophages.
Besides these receptors molecules, actively participated proteins and cellular mechanism system there is a lot of others factors in these mechanisms are linked like adhesins and invasins, biofilm formation, contact sensing and thigmotropism, secreted hydrolases, pH-sensing and its regulation, environment and metabolic adaptation, small HSPs, metal acquisition. So, for a complete understanding these factors also play significant role in pathogenicity mechanism of
6. Conclusion
This chapter has discussed the pathogenicity mechanism along with host and cellular responses in Candida species. Host reactions to Candida are profoundly assorted because of the assortment of contagious PAMPs and antigens perceived by various safe cells at different disease destinations. Many inquiries have been conducted on this important topic, particularly with
References
- 1.
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD et al (2009) EPIC II Group of Investigators. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323-2329 - 2.
Ingham CJ, Boonstra S, Levels S, de Lange M, Meis JF, Schneeberger PM (2012) Rapid susceptibility testing and microcolony analysis of Candida spp. cultured and imaged on porous aluminium oxide. PLoS ONE 7:e33818 - 3.
Correia A, Sampaio P, Vilanova M, Pais C (2015) Candida albicans : clinical relevance, pathogenesis, and host immunity. In: Sing SK (ed) Human emerging and re-emerging infections: viral and parasitic infections, vol 1. John Wiley and Sons, New Jersey, pp 926-952 - 4.
Limon JJ, Skalski JH, Underhill DM (2017) Commensal fungi in health and disease. Cell Host Microbes 22:156-165 - 5.
De Rosa FG, Garazzino S, Pasero DC, Peri GD (2009) Invasive candidiasis and candidemia: new guidelines. Minerva Anaestesiologica 75:453-458 - 6.
Negri M, Faria M, Guilhermetti E, Alves A, Paula C, Svidzinski T (2010) Hemolytic activity and production of germ tubes related to pathogenic potential of clinical isolates of Candida albicans . J Basic Appl Pharm. 31:89-93 - 7.
Silva S, Negri M, Henriques M, Oliveira R, Williams DW, Azeredo J (2011) Adherence and biofilm formation of non- Candida albicans Candida species. Trends Microbio 19:241-247 - 8.
Wisplinghoff H, Seifert H, Tallent SM, Bischoff T, Wenzel RP, Edmond MB (2003a) Nosocomial bloodstream infections in pediatric patients in United States hospitals: epidemiology, clinical features and susceptibilities. Pediatr Infect Dis J 22:686-691 - 9.
Bongomin F, Gago S, Oladele R, Denning D (2017) Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi 3:57 - 10.
Dadar M, Tiwari R, Karthik K, Chakraborty S, Shahali Y, Dhama K (2018) Candida albicans -biology, molecular characterization, pathogenicity, and advances in diagnosis and control-an update. Microb Pathog 117:128-138 - 11.
Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR et al (2019) Candida auris: a review of recommendations for detection and control in health care settings. J Fungi 5:111 - 12.
Aslam B,Wang W, Arshad MI, Khurshid M,Muzammil S, Rasool MH et al (2018) Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist 11:1645-1658 - 13.
Kornitzer D (2019) Regulation of Candida albicans hyphal morphogenesis by endogenous signals. J Fungi 5:21 - 14.
Wisplinghoff H, Elobers J, Geurtz L, Stefanik D, Major Y, Edmond MB et al (2014) Nosocomial bloodstream infections due to Candida spp. in the USA: species distribution, clinical features and antifungal susceptibilities. Int J Antimicrob Agents 43:78-81 - 15.
Perez JC, Johnson AD (2013) Regulatory circuits that enable proliferation of the fungus Candida albicans in a mammalian host. PLoS Pathogen 9(12):e1003780 - 16.
Jacobsen ID, Hube B (2017) Candida albicans morphology: still in focus. Expert Rev Anti Infect Ther 15:327-330 - 17.
AokiW, Kitahara N,Miura N, Morisaka H, Yamamoto Y, Kuroda K et al (2011) Comprehensive characterization of secreted aspartic proteases encoded by a virulence gene family in Candida albicans . J BioChem 150:431-438 - 18.
Seman BG, Moore JL, Scherer AK, Blair BA, Manandhar S, Jones JM et al (2018) Yeast and filaments have specialized, independent activities in a zebrafish model of Candida albicans infection. Infect Immun 86:e00415–e00418 - 19.
Desai JV, Cheng S, Ying T, NguyenMH, Clancy CJ, Lanni F et al (2015) Coordination of Candida albicans invasion and infection functions by phosphoglycerol phosphatase Rhr2. Pathogens 4: 573-589 - 20.
Kadosh D (2017) Morphogenesis in C. albicans . In: Prasad R (ed)Candida albicans : Cell Mol Biol. Springer, Cham - 21.
Han TL, Cannon RD, Villas-Boas SG (2011) The metabolic basis of Candida albicans morphogenesis and quorum sensing. Fungal Genet Biol 48:747-763 - 22.
Monge RA, Román E, Nombela C, Pla J (2006) The MAP kinase signal transduction network in Candida albicans . Microbiology 152:905-912 - 23.
Gong Y, Li T, Yu C, Sun S (2017) Candida albicans heat shock proteins and Hsps-associated signaling pathways as potential antifungal targets. Front Cell Infect Microbiol 7:520 - 24.
Smith DA, Nicholls S,Morgan BA, Brown AJP, Quinn JA (2004) Conserved stress-activated protein kinase regulates a core stress response in the human pathogen Candida albicans .Mol Biol Cell 15:4179-4190 - 25.
Hogan D, Sundrom P (2009) The Ras/Camp/PKA signaling pathways and virulence in Candida albicans . Future Microbiol 4: 1263-1270 - 26.
Lin C-J, Wu C-Y, Yu S-J, Chen Y-L (2018) Protein kinase A governs growth and virulence in Candida tropicalis . Virulence 9(1):331-347 - 27.
Inglis DO, Sherlock G (2013) Ras signaling gets fine-tuned: regulation of multiple pathogenic traits of Candida albicans . Eukaryot Cell 12:1316-1325 - 28.
Lin CJ, Chen YL (2018) Conserved and divergent functions of the cAMP/PKA signaling pathway in Candida albicans andCandida tropicalis . J Fungi 4:68 - 29.
DavisDA (2009) Howhuman pathogenic fungi sense and adapt to pH: the link to virulence. Curr Opin Microbiol 12:365-370 - 30.
Brown A, Haynes K, Gow N, Quinn J (2012) Stress responses in Candida, 2nd edn. ASM Press, Washington, D.C., pp 225-242 - 31.
Zhou Y, LiaoM, Zhu C, Hu Y, Tong T, Peng X et al (2018) ERG3 and ERG11 genes are critical for the pathogenesis of Candida albicans during the oral mucosal infection. Int J Oral Sci 10:9 - 32.
de Oliveira SGC, Vasconcelos CC, Lopes AJO, de Sousa Cartagenes MDS, Filho AKDB, do Nascimento FRF et al (2018) Candida infections and therapeutic strategies: mechanisms of action for traditional and alternative agents. Front Microbiol 9:1351 - 33.
Dantas SA, Lee KK, Raziunaite I, Schaefer K, Wagener J, Yadav B et al (2016) Cell biology of Candida albicans -host interactions. Curr Opin Microbiol 34:111-118 - 34.
Schonherr FA, Sparber F, Kirchner FR, Guiducci E, Trautweinweidner K, Gladiator A et al (2017) The interspecies diversity of C. albicans triggers qualitatively and temporally distinct host responses that determine the balance between commensalism and pathogenicity. Mucosal Immunol 10:1335-1350 - 35.
Braunsdorf C, LeibundGut-Landmann S (2018) Modulation of the fungal-host interaction by the intra-species diversity of C. albicans . Pathogens 7:11 - 36.
Reedy JL, Filler SG, Heitman J (2010) Elucidating the Candida albicans calcineurin signaling cascade controlling stress response and virulence. Fungal Genet Biol 47:107 - 37.
Liu S, Liu W (2015) Components of the canclium-calcinerium signaling pathways in fungal cells and their potential as antifungal targets. Eukaryot Cell 14:4 - 38.
Yu Q, Jia C, Dong Y, Zhang B, Xiao C, Chen Y et al (2015) Candida albicans autophagy, no longer a bystander: its role in tolerance to ER stress-related antifungal drugs. Fungal Genet Biol 81:238-249 - 39.
Shang-Jie Y, Ya-Lin C, Ying-Lie C (2015) Calcineurin signaling: lessons from Candida species. FEMS Microbiol 15:4 - 40.
Wang L, Lin X (2012) Morphogenesis in fungal pathogenesis: shape, size and surface. PLoS Pathog 8:e1003027 - 41.
Kim S, Nguyen QB,WolyniakMJ, Frechette G, Lehman CR, Fox BK et al (2018) Release of transcriptional repression through the HCR promoter region confers uniform expression of HWP1 on surfaces of Candida albicans germ tubes. PLoS ONE 13: e0192260 - 42.
Sharma J, Rosiana S, Razzaq I, Shapiro RS (2019) Linking cellular morphogenesis with antifungal treatment and susceptibility in Candida pathogens. J Fungi 5:17 - 43.
Sun JN, Solis NV, Phan QT, Bajwa JS, Kashlera H, Thompson A et al (2010) Host cell invasion and virulence mediated by Candida albicans Ssai. PLos Pathog 6:e1001181 - 44.
Wächtler B,Wilson D, Haedicke K, Dalle F, Hube B (2011) From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells. PLoS One 6:e17046 - 45.
C. A. Janeway Jr. and R. Medzhitov, “Innate immune recognition,” Annual Review of Immunology , vol. 20, pp. 197-216, 2002 - 46.
M. G. Netea, G. D. Brown, B. J. Kullberg, and N. A. R. Gow, “An integrated model of the recognition of Candida albicans by the innate immune system,“Nature ReviewsMicrobiology , vol. 6, no. 1, pp. 67-78, 2008 - 47.
J. R. Naglik and D. Moyes, “Epithelial cell innate response to Candida albicans .,”Advances in dental research , vol. 23, no. 1, pp. 50-55, 2011 - 48.
A. Roeder, C. J. Kirschning, R. A. Rupec, M. Schaller,G.Weindl, and H. C. Korting, “Toll-like receptors as key mediators in innate antifungal immunity,” Medical Mycology , vol. 42, no. 6, pp. 485-498, 2004 - 49.
G. Weindl, J. Wagener, and M. Schaller, “Epithelial cells and innate antifungal defense,” Journal of Dental Research , vol. 89, no. 7, pp. 666-675, 2010 - 50.
A. Plato, J. A. Willment, and G. D. Brown, “C-Type lectinlike receptors of the dectin-1 cluster: Ligands and signalling pathways,” International Reviews of Immunology , vol. 32, no. 2, pp. 134-156, 2013 - 51.
D. J. Philpott, M. T. Sorbara, S. J. Robertson, K. Croitoru, and S. E. Girardin, “NOD proteins: regulators of inflammation in health and disease,” Nature Reviews Immunology , vol. 14, pp. 9-23, 2014 - 52.
C. Bourgeois and K. Kuchler, “Fungal pathogens—a sweet and sour treat for toll-like receptors,” Frontiers in Cellular and Infection Microbiology , vol. 2, article 142, 2012 - 53.
S. Akira, “Mammalian Toll-like receptors,” Current Opinion in Immunology , vol. 15, no. 1, pp. 5-11, 2003 - 54.
K. Takeda, T. Kaisho, and S. Akira, “Toll-like receptors,” Annual Review of Immunology , vol. 21, pp. 335-376, 2003 - 55.
S. Akira and K. Takeda, “Toll-like receptor signalling,” Nature Reviews Immunology , vol. 4, no. 7, pp. 499-511, 2004 - 56.
K. Takeda and S. Akira, “TLR signaling pathways,” Seminars in Immunology , vol. 16, no. 1, pp. 3-9, 2004 - 57.
T. Kawai and S. Akira, “Pathogen recognition with Toll-like receptors,” Current Opinion in Immunology , vol. 17, no. 4, pp. 338-344, 2005 - 58.
T. Kawai and S. Akira, “TLR signaling,” Seminars in Immunology , vol. 19, no. 1, pp. 24-32, 2007 - 59.
B. Lemaitre, E. Nicolas, L. Michaut, J. Reichhart, and J. A. Hoffmann, “The dorsoventral regulatory gene cassette spatzle/Toll/Cactus controls the potent antifungal response in Drosophila adults,” Cell , vol. 86, no. 6, pp. 973-983, 1996 - 60.
T. Jouault, S. Ibata-Ombetta, O. Takeuchi et al., “ Candida albicans phospholipomannan is sensed through toll-like receptors,”Journal of Infectious Diseases , vol. 188, no. 1, pp. 165-172, 2003 - 61.
G. D. Brown, P. R. Taylor, D.M. Reid et al., “Dectin-1 is a major 𝛽-glucan receptor on macrophages,” Journal of Experimental Medicine , vol. 196, no. 3, pp. 407-412, 2002 - 62.
K. M. Dennehy, J. A. Willment, D. L. Williams, and G. D. Brown, “Reciprocal regulation of IL-23 and IL-12 following coactivation of dectin-1 and TLR signaling pathways,” European Journal of Immunology , vol. 39, no. 5, pp. 1379-1386, 2009 - 63.
M. G. Netea, N. A. R. Gow, C. A. Munro et al., “Immune sensing of Candida albicans requires cooperative recognition of mannans and glucans by lectin and Toll-like receptors,”Journal of Clinical Investigation , vol. 116, no. 6, pp. 1642-1650, 2006 - 64.
G. Ferwerda, F. Meyer-Wentrup, B. Kullberg, M. G. Netea, and G. J. Adema, “Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages,” Cellular Microbiology , vol. 10, no. 10, pp. 2058– 2066, 2008 - 65.
A.Ozinsky, D.M.Underhill, J.D. Fontenot et al., “The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors,” Proceedings of the National Academy of Sciences of the United States of America , vol. 97, no. 25, pp. 13766-13771, 2000 - 66.
M. G. Netea, F. Van De Veerdonk, I. Verschueren, J.W. M. Van DerMeer, andB. J. Kullberg, “RoleofTLR1 andTLR6 in thehost defense against disseminated candidiasis,” FEMS Immunology and Medical Microbiology , vol. 52, no. 1, pp. 118-123, 2008 - 67.
S. P. Smeekens, F. L. van de Veerdonk, J. W. M. van der Meer, B. J. Kullberg, L. A. B. Joosten, andM. G.Netea, “The Candida Th17 response is dependent on mannanand 𝛽-glucan-induced prostaglandin E2,” International Immunology , vol. 22, no. 11, pp. 889-895, 2010 - 68.
T. Jouault, M. El Abed-El Behi, M. Mart’ınez-Esparza et al., “Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminateSaccharomyces cerevisiae and needs association with TLR2 for signaling,”Journal of Immunology , vol. 177, no. 7, pp. 4679-4687, 2006 - 69.
K. Sato, X. Yang, T. Yudate et al., “Dectin-2 is a pattern recognition receptor for fungi that couples with the Fc receptor 𝛾 chain to induce innate immune responses,” The Journal of Biological Chemistry , vol. 281, no. 50, pp. 38854-38866, 2006 - 70.
C. A. Wells, J. A. Salvage-Jones, X. Li et al., “The macrophageinducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans ,”Journal of Immunology , vol. 180, no. 11, pp. 7404-7413, 2008 - 71.
A. Cambi, K. Gijzen, I. J. M. de Vries et al., “The C-type lectin DC-SIGN (CD209) is an antigen-uptake receptor for Candida albicans on dendritic cells,”European Journal of Immunology , vol. 33, no. 2, pp. 532-538, 2003 - 72.
P.R.Taylor,G.D. Brown, J.Herre,D. L.Williams, J. A.Willment, and S.Gordon, “TheRole of SIGNR1 and the 𝛽-GlucanReceptor (Dectin-1) in the Nonopsonic Recognition of Yeast by Specific Macrophages,” Journal of Immunology , vol. 172, no. 2, pp. 1157-1162, 2004 - 73.
M. G. Netea and B. J. Kullberg, “Epithelial sensing of fungal invasion,” Cell Host andMicrobe , vol. 8, no. 3, pp. 219-220, 2010 - 74.
A. Esteban, M.W. Popp, V. K. Vyas, K. Strijbis,H. L. Ploegh, and G. R. Fink, “Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages,” Proceedings of the National Academy of Sciences of the United States of America , vol. 108, no. 34, pp. 14270-14275, 2011 - 75.
L. Romani , “Immunity to fungal infections,”Nature Reviews Immunology , vol. 11, no. 4, pp. 275-288, 2011 - 76.
L. B. Ivashkiv, “A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways,” Nature Reviews Immunology , vol. 8, no. 10, pp. 816-822, 2008 - 77.
S. V. Tsoni and G. D. Brown, “𝛽-Glucans and dectin-1,” Annals of the New York Academy of Sciences , vol. 1143, pp. 45-60, 2008 - 78.
E. F. Kenny and L. A. J. O’Neill, “Signalling adaptors used by Toll-like receptors: an update,” Cytokine , vol. 43, no. 3, pp. 342-349, 2008 - 79.
L. A. J. O’Neill, “The interleukin-1 receptor/Toll-like receptor superfamily: 10 Years of progress,” Immunological Reviews , vol. 226, no. 1, pp. 10-18, 2008 - 80.
E. Villam’on, D. Gozalbo, P. Roig et al., “Myeloid differentiation factor 88 (MyD88) is required formurine resistance to Candida albicans and is critically involved in Candida-induced production of cytokines,”European Cytokine Network , vol. 15, no. 3, pp. 263-271, 2004 - 81.
C. Bourgeois,O.Majer, I. E. Frohner, L. Tierney, and K. Kuchler, “Fungal attacks on mammalian hosts: pathogen elimination requires sensing and tasting,” Current Opinion in Microbiology , vol. 13, no. 4, pp. 401-408, 2010 - 82.
S. Bellocchio, C. Montagnoli, S. Bozza et al., “The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo,” The Journal of Immunology , vol. 172, no. 5, pp. 3059-3069, 2004 - 83.
M. L. Gil andD. Gozalbo, “Role of toll-like receptors insystemic Candida albicans infections,”Frontiers in Bioscience , vol. 14, no. 2, pp. 570-582, 2009 - 84.
M. G. Netea, C. A. A. van der Graaf, A. G. Vonk, I.Verschueren, J. W. M. Van der Meet, and B. J. Kullberg, “The role of tolllike receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis,” Journal of Infectious Diseases , vol. 185, no. 10, pp. 1483-1489, 2002 - 85.
M.G.Netea, R. Sutmuller, C.Hermann et al., “Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells,”Journal of Immunology , vol.172, no. 6, pp. 3712-3718, 2004 - 86.
M. G. Netea, N. A. R. Gow, L. A. B. Joosten, I. Verschueren, J. W. M. Van Der Meer, and B. J. Kullberg, “Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors,”Medical Mycology , vol. 48, no. 7, pp. 897-903, 2010 - 87.
E. Villam’on, D. Gozalbo, P. Roig et al., “Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis,”Microbes and Infection , vol. 6, no. 6, pp. 542-548, 2004 - 88.
C. Murciano, E. Villamon, D. Gozalbo, P. Roig, J. E. O’Connor, and M. L. Gil, “Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection,”Medical Mycology , vol. 44, no. 2, pp. 149-157, 2006 - 89.
C. Bourgeois, O. Majer, I. E. Frohner et al., “Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-𝛽 signaling,” Journal of Immunology , vol. 186, no. 5, pp. 3104-3112, 2011 - 90.
A. Miyazato, K. Nakamura, N. Yamamoto et al., “Toll-like receptor 9-dependent activation of myeloid dendritic cells by deoxynucleic acids from Candida albicans ,”Infection and Immunity , vol. 77, no. 7, pp. 3056-3064, 2009 - 91.
F. L. van de Veerdonk, M. G. Netea, T. J. Jansen et al., “Redundant role of TLR9 for anti-Candida host defense,” Immunobiology , vol. 213, no. 8, pp. 613-620, 2008 - 92.
C. Biondo, G. Signorino, A. Costa et al., “Recognition of yeast nucleic acids triggers a host-protective type I interferon response,” European Journal of Immunology , vol. 41, no. 7, pp. 1969-1979, 2011 - 93.
J. Magarian Blander and R. Medzhitov, “Toll-dependent selection of microbial antigens for presentation by dendritic cells,” Nature , vol. 440, no. 7085, pp. 808-812, 2006 - 94.
T. S. Plantinga, M.D. Johnson,W. K. Scott et al., “Human genetic susceptibility to Candida infections,” MedicalMycology , vol. 50, no. 8, pp. 785-794, 2012 - 95.
T. S. Plantinga,M.D. Johnson,W.K. Scott et al., “Toll-like receptor 1 polymorphisms increase susceptibility to candidemia,” Journal of Infectious Diseases , vol. 205, no. 6, pp. 934-943, 2012 - 96.
A. Nahum, H. Dadi, A. Bates, and C. M. Roifman, “The L412F variant of Toll-like receptor 3 (TLR3) is associated with cutaneous candidiasis, increased susceptibility to cytomegalovirus, and autoimmunity,” Journal of Allergy and Clinical Immunology , vol. 127, no. 2, pp. 528-531, 2011 - 97.
A. Nahum, H. Dadi, A. Bates, and C. M. Roifman, “The biological significance of TLR3 variant, L412F, in conferring susceptibility to cutaneous candidiasis, CMV and autoimmunity,” Autoimmunity Reviews , vol. 11, no. 5, pp. 341-347, 2012 - 98.
C. A. A. Van der Graaf, M. G. Netea, S. A. Morr’e et al., “Tolllike receptor 4 Asp299Gly/Thr399Ile polymorphisms are a risk factor for Candida bloodstream infection,” European Cytokine Network , vol. 17, no. 1, pp. 29-34, 2006 - 99.
A. N. Zelensky and J. E. Gready, “The C-type lectin-like domain superfamily,” FEBS Journal , vol. 272, no. 24, pp. 6179-6217, 2005 - 100.
S. E. Hardison and G. D. Brown, “C-type lectin receptors orchestrate antifungal immunity,” Nature Immunology , vol. 13, no. 9, pp. 817-822, 2012 - 101.
J. A. Willment and G. D. Brown, “C-type lectin receptors in antifungal immunity,” Trends in Microbiology , vol. 16, no. 1, pp. 27-32, 2008 - 102.
G. D. Brown, “Dectin-1 : a signalling non-TLR patternrecognition receptor,” Nature Reviews Immunology , vol. 6, no. 1, pp. 33-43, 2006 - 103.
S. I.Gringhuis, J. denDunnen,M. Litjens et al., “Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-𝜅B activation through Raf-1 and Syk,” Nature Immunology , vol. 10, no. 2, pp. 203-213, 2009 - 104.
D. M. Reid, N. A. Gow, and G. D. Brown, “Pattern recognition: recent insights fromDectin-1,” Current Opinion in Immunology , vol. 21, no. 1, pp. 30-37, 2009 - 105.
J. Herre, J. A. Willment, S. Gordon, and G. D. Brown, “The role of dectin-1 in antifungal immunity,” Critical Reviews in Immunology , vol. 24, no. 3, pp. 193-203, 2004 - 106.
H. S. Goodridge, C. N. Reyes, C. A. Becker et al., “Activation of the innate immune receptor Dectin-1 upon formation of a ‘Phagocytic synapse’,” Nature , vol. 472, no. 7344, pp. 471-475, 2011 - 107.
G. D. Brown, J. Herre, D. L. Williams, J. A. Willment, A. S. J. Marshall, and S. Gordon, “Dectin-1 mediates the biological effects of 𝛽-glucans,” Journal of ExperimentalMedicine , vol. 197, no. 9, pp. 1119-1124, 2003 - 108.
S. Dillon, S. Agrawal, K. Banerjee et al., “Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigenpresenting cells and immunological tolerance,” Journal of Clinical Investigation , vol. 116, no. 4, pp. 916-928, 2006 - 109.
B. N. Gantner, R. M. Simmons, S. J. Canavera, S. Akira, and D. M. Underhill, “Collaborative induction of inflammatory responses by dectin-1 and toll-like receptor 2,” Journal of Experimental Medicine , vol. 197, no. 9, pp. 1107-1117, 2003 - 110.
C. A. Rappleye, L. G. Eissenberg, and W. E. Goldman, “Histoplasma capsulatum𝛼-(1,3)-glucan blocks innateimmune recognition by the 𝛽-glucan receptor,” Proceedings of the National Academy of Sciences of the United States of America , vol. 104, no. 4, pp. 1366-1370, 2007 - 111.
D. W. Lowman, R. R. Greene, D. W. Bearden et al., “Novel structural features in Candida albicans hyphal glucan provide a basis for differential innate immune recognition of hyphae versus yeast,”The Journal of Biological Chemistry , vol. 289, pp. 3432-3443, 2014 - 112.
P. J. Rice, E. L. Adams, T. Ozment-Skelton et al., “Oral delivery and gastrointestinal absorption of soluble glucans stimulate increased resistance to infectious challenge,” Journal of Pharmacology and ExperimentalTherapeutics , vol. 314, no. 3, pp. 1079-1086, 2005 - 113.
S. E. Evans, P. Y. Hahn, F. McCann, T. J. Kottom, Z. V. Pavlovi’c, and A. H. Limper, “Pneumocystis cell wall 𝛽-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-𝜅𝛽-dependent mechanisms,” The American Journal of Respiratory Cell and Molecular Biology , vol. 32, no. 6, pp. 490-497, 2005 - 114.
H. Lee, J. Yuk, D. Shin, and E. Jo, “Dectin-1 is inducible and plays an essential role for mycobacteria-induced innate immune responses in airway epithelial cells,” Journal of Clinical Immunology , vol. 29, no. 6, pp. 795-805, 2009 - 115.
D. L.Moyes, M. Runglall, C.Murciano et al., “A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells,”Cell Host and Microbe , vol. 8, no. 3, pp. 225-235, 2010 - 116.
D. L. Moyes, C. Shen, C. Murciano et al., “Protection against epithelial damage during Candida albicans infection is mediated by PI3K/Akt and mammalian target of rapamycin signaling,”Journal of InfectiousDiseases , vol. 209, no. 11,pp. 1816-1826, 2014 - 117.
J. Wagener, G. Weindl, P. W. J. de Groot et al., “Glycosylation of Candida albicans cell wall proteins is critical for induction of innateimmune responses and apoptosis of epithelial cells,”PLoS ONE , vol. 7, no. 11,Article ID e50518, 2012 - 118.
S. Saijo, N. Fujikado, T. Furuta et al., “Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans ,”Nature Immunology , vol. 8, no. 1, pp. 39-46, 2007 - 119.
P. R. Taylor, S. V. Tsoni, J. A. Willment et al., “Dectin-1 is required for 𝛽-glucan recognition and control of fungal infection,” Nature Immunology , vol. 8, no. 1, pp. 31-38, 2007 - 120.
O.Gross, A.Gewies, K. Finger et al., “Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity,” Nature , vol. 442, no. 7103, pp. 651-656, 2006 - 121.
A. Puel, S. Cypowyj, J. Bustamante et al., “Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity,” Science , vol. 332, no. 6025, pp. 65-68, 2011 - 122.
D. C. Rosentul, T. S. Plantinga, M. Oosting et al., “Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia,” Journal of Infectious Diseases , vol. 204, no. 7, pp. 1138-1145, 2011 - 123.
I. D. Iliev, V. A. Funari, K. D. Taylor et al., “Interactions between commensal fungi and the C-type lectin receptor dectin-1 influence colitis,” Science , vol. 336, no. 6086, pp. 1314-1317, 2012 - 124.
S. Vautier, R. A. Drummond, P. Redelinghuys, G. I. Murray, D. M. MacCallum, and G. D. Brown, “Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract,”Infection and Immunity , vol. 80,no. 12, pp. 4216-4222, 2012 - 125.
B. Ferwerda, G. Ferwerda, T. S. Plantinga et al., “Human dectin-1 deficiency and mucocutaneous fungal infections,” The New England Journal ofMedicine , vol. 361, no. 18, pp. 1760-1767, 2009 - 126.
T. S. Plantinga, W. J. F. M. Van Der Velden, B. Ferwerda et al., “Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients,” Clinical Infectious Diseases , vol. 49, no. 5, pp. 724-732, 2009 - 127.
T. S. Plantinga, O. J. M. Hamza, J. A. Willment et al., “Genetic variation of innate immune genes in HIV-infected African patients with or without oropharyngeal candidiasis,” Journal of Acquired ImmuneDeficiency Syndromes , vol. 55,no. 1, pp. 87-94, 2010 - 128.
L.M. Grahamand G. D. Brown, “TheDectin-2 family of C-type lectins in immunity and homeostasis,” Cytokine , vol. 48, no. 1-2, pp. 148-155, 2009 - 129.
E. P. McGreal, M. Rosas, G. D. Brown et al., “The carbohydrate recognition domain of Dectin-2 is a C-type lectin with specificity for high mannose,” Glycobiology , vol. 16, no. 5, pp. 422-430, 2006 - 130.
S. Saijo, S. Ikeda, K. Yamabe et al., “Dectin-2 recognition of 𝛼-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans ,”Immunity , vol. 32, no. 5, pp. 681-691, 2010 - 131.
M. J. Robinson, F. Osorio, M. Rosas et al., “Dectin-2 is a Syk coupled pattern recognition receptor crucial forTh17 responses to fungal infection,” Journal of Experimental Medicine , vol. 206, no. 9, pp. 2037-2051, 2009 - 132.
N. Hirata, K. Ishibashi, W. Sato et al., “Beta-mannosyl linkages inhibit CAWS arteritis by negatively regulating dectin-2-dependent signaling in spleen and dendritic cells,” Immunopharmacology and Immunotoxicology , vol. 35, pp. 594-604, 2013 - 133.
B. Kerscher, J. A. Willment, and G. D. Brown, “The Dectin-2 family of C-type lectin-like receptors: an update,” International Immunology , vol. 25, no. 5, pp. 271-277, 2013 - 134.
D. C. Ifrim, J. M. Bain,D. M. Reid et al., “The role of Dectin-2 for host defense against systemic infection with Candida glabrata ,”Infection and Immunity , vol. 82, no. 3, pp. 1064-1073, 2014 - 135.
L. Zhu, X. Zhao, C. Jiang et al., “C-type lectin receptors dectin-3 and dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection,” Immunity , vol. 39, no. 2, pp. 324-334, 2013 - 136.
A. Cambi, M. G. Netea, H. M. Mora-Montes et al., “Dendritic cell interaction with Candida albicans critically depends on Nlinked Mannan,”The Journal of Biological Chemistry , vol. 283, no. 29, pp. 20590-20599, 2008 - 137.
J. S. Lam, H. Huang, and S. M. Levitz, “Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells,” PLoS ONE , vol. 2, no. 10, Article ID e1009, 2007 - 138.
P. R. Taylor, S. Gordon, and L. Martinez-Pomares, “The mannose receptor: linking homeostasis and immunity through sugar recognition,” Trends in Immunology , vol. 26, no. 2, pp. 104-110, 2005 - 139.
U. Gazi,M. Rosas, S. Singh et al., “Fungal recognition enhances mannose receptor shedding through dectin-1 engagement,” Journal of Biological Chemistry , vol. 286, no. 10, pp. 7822-7829, 2011 - 140.
F. L. van de Veerdonk, R. J. Marijnissen, B. J. Kullberg et al., “The macrophage mannose receptor induces IL-17 in response to Candida albicans ,”Cell Host and Microbe , vol. 5, no. 4, pp. 329-340, 2009 - 141.
S. E.M. Heinsbroek, P. R. Taylor, F. O.Martinez, L. Martinez- Pomares, G. D. Brown, and S. Gordon, “Stage-specific sampling by pattern recognition receptors during Candida albicans phagocytosis,”PLoS Pathogens , vol. 4, no. 11, Article ID e1000218, 2008 - 142.
J. Zhang, S. D. Tachado, N. Patel et al., “Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro,” Journal of Leukocyte Biology , vol. 78, no. 3, pp. 665-674, 2005 - 143.
S. J. Lee,N. Zheng,M. Clavijo, andM.C.Nussenzweig, “Normal host defense during systemic candidiasis in mannose receptordeficient mice,” Infection and Immunity , vol. 71, no. 1, pp. 437-445, 2003 - 144.
J. M. Dan, R. M. Kelly, C. K. Lee, and S. M. Levitz, “Role of the mannose receptor in a murine model of Cryptococcus neoformans infection,”Infection and Immunity , vol. 76, no. 6, pp. 2362-2367, 2008 - 145.
F. Martinon, A. Mayor, and J. Tschopp, “The inflammasomes: guardians of the body,” Annual Review of Immunology , vol. 27, pp. 229-265, 2009 - 146.
H. Kumar, T. Kawai, and S. Akira, “Pathogen recognition by the innate immune system,” International Reviews of Immunology , vol. 30, no. 1, pp. 16-34, 2011 - 147.
C. Bryant and K. A. Fitzgerald, “Molecular mechanisms involved in inflammasome activation,” Trends in Cell Biology , vol. 19, no. 9, pp. 455-464, 2009 - 148.
C. A. A. Van Der Graaf, M. G. Netea, B. Franke, S. E. Girardin, J.W. M. VanDerMeer, and B. J. Kullberg, “Nucleotide oligomerization domain 2 (Nod2) is not involved in the pattern recognition of Candida albicans ,”Clinical andVaccine Immunology , vol. 13, no. 3, pp. 423-425, 2006 - 149.
S. Joly, N. Ma, J. J. Sadler, D. R. Soll, S. L. Cassel, and F. S. Sutterwala, “Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome,”Journal of Immunology , vol. 183, no. 6, pp. 3578-3581, 2009 - 150.
J. Tomalka, S. Ganesan, E. Azodi et al., “A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans ,”PLoS Pathogens , vol. 7, no. 12, Article ID e1002379, 2011 - 151.
J. A. Kummer, R. Broekhuizen,H. Everett et al., “Inflammasome componentsNALP 1 and 3 showdistinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response,” Journal of Histochemistry and Cytochemistry , vol. 55, no. 5, pp. 443-452, 2007 - 152.
Y.Mostefaoui, I.Claveau, andM. Rouabhia, “In vitro analyses of tissue structure and interleukin-1𝛽 expression and production by human oral mucosa in response to Candida albicans infections,”Cytokine , vol. 25, no. 4, pp. 162-171, 2004 - 153.
M. Rouabhia, G. Ross, N. Pag’e, and J. Chakir, “Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation,”Infection and Immunity , vol. 70, no. 12, pp. 7073-7080, 2002 - 154.
G.Weindl, J. R. Naglik, S. Kaesler et al., “Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling,” The Journal of Clinical Investigation , vol. 117, no. 12, pp. 3664-3672, 2007 - 155.
F. Tardif, J. Goulet, A. Zakrazewski, P. Chauvin, and M. Rouabhia, “Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis,” Medical Science Monitor , vol. 10, no. 8, pp. BR239–BR249, 2004 - 156.
O. Gross, H. Poeck, M. Bscheider et al., “Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence,” Nature , vol. 459, no. 7245, pp. 433-436, 2009 - 157.
F. L. van de Veerdonk, B. J. Kullberg, J. W. van der Meer, N. A. Gow, and M. G. Netea, “Host-microbe interactions: innate pattern recognition of fungal pathogens,” Current Opinion in Microbiology , vol. 11, no. 4, pp. 305-312, 2008 - 158.
A. G. Vonk,M.G.Netea, J.H.VanKrieken, Y. Iwakura, J.W. M. VanDerMeer, and B. J.Kullberg, “Endogenous interleukin (IL)-1𝛼 and IL-1𝛽 are crucial for host defense against disseminated candidiasis,” The Journal of Infectious Diseases , vol. 193, no. 10, pp. 1419-1426, 2006 - 159.
A. G. Hise, J. Tomalka, S. Ganesan et al., “An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans ,”Cell Host and Microbe , vol. 5, no. 5, pp. 487-497, 2009 - 160.
M. H. Zaki,K.L.Boyd, P. Vogel,M. B. Kastan,M.Lamkanfi, and T. Kanneganti, “The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis,” Immunity , vol. 32, no. 3, pp. 379-391, 2010 - 161.
L. M. Rehaume, T. Jouault, andM. Chamaillard, “Lessons from the inflammasome: a molecular sentry linking Candida and Crohn’s disease,” Trends in Immunology , vol. 31, no. 5, pp. 171-175, 2010 - 162.
A. Lev-Sagie, D. Prus, I. M. Linhares, Y. Lavy, W. J. Ledger, and S. S. Witkin, “Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome,” The American Journal of Obstetrics and Gynecology , vol. 200, no. 3, pp. 303.e1-303.e6, 2009 - 163.
S. Yamasaki, M. Matsumoto, O. Takeuchi et al., “C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia,” Proceedings of the National Academy of Sciences of the United States of America , vol. 106, no. 6, pp. 1897-1902, 2009 - 164.
A. Bugarcic, K. Hitchens, A. G. Beckhouse, C. A. Wells, R. B. Ashman, and H. Blanchard, “Human and mouse macrophageinducible C-type lectin (Mincle) bind Candida albicans ,”Glycobiology , vol. 18, no. 9, pp. 679-685, 2008 - 165.
D. Vijayan, K. J. Radford, A. G. Beckhouse, R. B. Ashman, and C. A.Wells, “Mincle polarizes humanmonocyte and neutrophil responses to Candida albicans ,”Immunology and Cell Biology , vol. 90, no. 9, pp. 889-895, 2012 - 166.
M. Da Gl’oria Sousa, D. M. Reid, E. Schweighoffer et al., “Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin,”Cell Host and Microbe , vol. 9, no. 5, pp. 436-443, 2011 - 167.
W. Lee, J. Kang, J. Yan et al., “Neutrophils promote mycobacterial trehalose dimycolate-induced lung inflammation via the mincle pathway,” PLoS Pathogens , vol. 8, no. 4, Article ID e1002614, 2012 - 168.
P. F. Zipfel, “Complement and immune defense: From innate immunity to human diseases,” Immunology Letters , vol. 126, no. 1-2, pp. 1-7, 2009 - 169.
P. F. Zipfel and C. Skerka, “Complement, Candida, and cytokines: the role of C5a in host response to fungi,” European Journal of Immunology , vol. 42, no. 4, pp. 822-825, 2012 - 170.
S. Luo, C. Skerka, O. Kurzai, and P. F. Zipfel, “Complement and innate immune evasion strategies of the human pathogenic fungus Candida albicans ,“Molecular Immunology , vol. 56, no. 3, pp. 161-169, 2013 - 171.
C. Speth, G. Rambach, R. W¨urzner, and C. Lass-Fl¨orl, “Complement and fungal pathogens: an update,” Mycoses , vol. 51, no. 6, pp. 477-496, 2008 - 172.
N. Brouwer, K. M. Dolman, M. van Houdt, M. Sta, D. Roos, and T. W. Kuijpers, “Mannose-binding lectin (MBL) facilitates opsonophagocytosis of yeasts but not of bacteria despite MBL binding,” Journal of Immunology , vol. 180, no. 6, pp. 4124-4132, 2008 - 173.
O. Neth, D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner, “Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition,” Infection and Immunity , vol. 68, no. 2, pp. 688-693, 2000 - 174.
C. B. Forsyth and H. L. Mathews, “Lymphocytes utilize CD11b/CD18 for adhesion to Candida albicans ,”Cellular Immunology , vol. 170, no. 1, pp. 91-100, 1996 - 175.
T. Meri, A. Hartmann, D. Lenk et al., “The yeast Candida albicans binds complement regulators factor H and FHL-1,”Infection and Immunity , vol. 70, no. 9, pp. 5185-5192, 2002 - 176.
T. Meri, A.M. Blom, A. Hartmann, D. Lenk, S. Meri, and P. F. Zipfel, “The hyphal and yeast forms of Candida albicans bind the complement regulator C4b-binding protein,”Infection and Immunity , vol. 72, no. 11, pp. 6633-6641, 2004 - 177.
V. Agarwal, T. M. Asmat, S. Luo, I. Jensch, P. F. Zipfel, and S. Hammerschmidt, “Complement regulator factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells,” The Journal of Biological Chemistry , vol. 285, no. 30, pp. 23486-23495, 2010 - 178.
S. Poltermann, A. Kunert, M. Von Der Heide, R. Eck, A. Hartmann, and P. F. Zipfel, “Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans ,”Journal of Biological Chemistry , vol. 282, no. 52, pp. 37537-37544, 2007 - 179.
S. Luo, S. Poltermann, A. Kunert, S. Rupp, and P. F. Zipfel, “Immune evasion of the human pathogenic yeast Candida albicans : Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein,“Molecular Immunology , vol. 47,no. 2-3, pp. 541-550, 2009 - 180.
S.Luo,A.M.Blom, S. Ruppet al., “ThepH-regulatedantigen1of Candida albicans binds the human complement inhibitor C4bbinding protein and mediates fungal complement evasion,”Journal of Biological Chemistry , vol. 286, no. 10, pp. 8021-8029, 2011 - 181.
S. Luo, A. Hartmann, H. Dahse, C. Skerka, and P. F. Zipfel, “Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3,”Journal of Immunology , vol. 185, no. 4, pp. 2164-2173, 2010 - 182.
R. B. Ashman, J. M. Papadimitriou, A. Fulurija et al., “Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice,” Microbial Pathogenesis , vol. 34, no. 2, pp. 103-113, 2003 - 183.
R. B. Ashman, E. M. Bolitho, and J.M. Papadimitriou, “Patterns of resistance to Candida albicans in inbred mouse strains,”Immunology and Cell Biology , vol. 71, no. 3, pp. 221-225, 1993 - 184.
R. B. Ashman, “Genetic determination of susceptibility and resistance in the pathogenesis of Candida albicans infection,”FEMS Immunology and Medical Microbiology , vol. 19, no. 3, pp. 183-189, 1997 - 185.
I. Radovanovic, A. Mullick, and P. Gros, “Genetic control of susceptibility to infection with Candida albicans in mice,”PLoS ONE , vol. 6, no. 4,Article ID e18957, 2011 - 186.
A. Mullick, M. Elias , S. Picard et al., “Dysregulated inflammatory response toCandida albicans in a C5-deficient mouse strain,”Infection and Immunity , vol. 72, no. 10, pp. 5868-5876, 2004 - 187.
A. Mullick, Z. Leon, G. Min-Oo et al., “Cardiac failure in C5- deficient A/J mice after Candida albicans infection,”Infection and Immunity , vol. 74, no. 8, pp. 4439-4451, 2006 - 188.
S.V. Tsoni, A.M. Kerrigan,M. J.Marakalala et al., “Complement C3 plays an essential role in the control of opportunistic fungal infections,” Infection and Immunity , vol. 77, no. 9, pp. 3679-3685, 2009 - 189.
C. B. Forsyth and H. L. Mathews, “Lymphocyte adhesion to Candida albicans ,”Infection and Immunity , vol. 70, no. 2, pp. 517-527, 2002 - 190.
W. K. Ip and Y. L. Lau, “Role of mannose-binding lectin in the innate defense against Candida albicans : enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells,”Journal of Infectious Diseases , vol. 190, no. 3, pp. 632-640, 2004 - 191.
M. C. Ghezzi, G. Raponi, S. Angeletti, and C.Mancini, “Serummediated enhancement of TNF-𝛼 release by human monocytes stimulated with the yeast form of Candida albicans ,”Journal of Infectious Diseases , vol. 178, no. 6, pp. 1743-1749, 1998 - 192.
A. Sonesson, L. Ringstad, E. Andersson Nordahl, M.Malmsten, M. M¨orgelin, and A. Schmidtchen, “Antifungal activity of C3a and C3a-derived peptides against Candida,” Biochimica et Biophysica Acta—Biomembranes , vol. 1768, no. 2, pp. 346-353, 2007 - 193.
P. Miram’on, L. Kasper, and B. Hube, “Thriving within the host: candida spp. interactions with phagocytic cells,” Medical Microbiology and Immunology , vol. 202, no. 3, pp. 183-195, 2013 - 194.
E. Svobodov’a, P. Staib, J. Losse, F. Hennicke, D. Barz, and M. J’ozsi, “Differential interaction of the two related fungal species Candida albicans and Candida dubliniensis with human neutrophils,”Journal of Immunology , vol. 189, no. 5, pp. 2502-2511, 2012 - 195.
J. R. Linden, M. A. MacCani, S. S. Laforce-Nesbitt, and J. M Bliss, “High efficiency opsonin-independent phagocytosis of Candida parapsilosis by human neutrophils,”MedicalMycology , vol. 48, no. 2, pp. 355-364, 2010 - 196.
W. L. Lee, R. E. Harrison, and S. Grinstein, “Phagocytosis by neutrophils,” Microbes and Infection , vol. 5, no. 14, pp. 1299-1306, 2003 - 197.
B. Amulic, C. Cazalet, G. L. Hayes, K. D. Metzler, and A. Zychlinsky, “Neutrophil function: From mechanisms to disease,” Annual Review of Immunology , vol. 30, pp. 459-489, 2012 - 198.
B. H. Segal, M. J. Grimm, A. N. H. Khan, W. Han, and T. S. Blackwell, “Regulation of innateimmunity byNADPHoxidase,” FreeRadical Biology andMedicine , vol. 53,no. 1, pp. 72-80, 2012 - 199.
F. C. Fang, “Antimicrobial reactive oxygen and nitrogen species: concepts and controversies,” Nature Reviews Microbiology , vol. 2, no. 10, pp. 820-832, 2004 - 200.
C. C. Winterbourn, M. B. Hampton, J. H. Livesey, and A. J. Kettle, “Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing,” Journal of Biological Chemistry , vol. 281, no. 52, pp. 39860-39869, 2006 - 201.
C. F. Urban, U. Reichard, V. Brinkmann, and A. Zychlinsky, “Neutrophil extracellular traps capture and kill Candida albicans and hyphal forms,”Cellular Microbiology , vol. 8, no. 4, pp. 668-676, 2006 - 202.
C. F. Urban, D. Ermert, M. Schmid et al., “Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans ,”PLoS Pathogens , vol. 5, no. 10, Article IDe1000639, 2009 - 203.
K. Seider, A. Heyken, A. L¨uttich, P. Miram’on, and B. Hube, “Interaction of pathogenic yeasts with phagocytes: survival, persistence and escape,” Current Opinion in Microbiology , vol. 13, no. 4, pp. 392-400, 2010 - 204.
P. Perumal, S. Mekala, C. Nombela, W. L. Chaffin, and C. Gil, “Proteomic analysis of cytoplasmic and surface proteins from yeast cells, hyphae, and biofilms of Candida albicans ,”Proteomics , vol. 9, no. 8, pp. 2230-2252, 2009 - 205.
F. O. Martinez, L. Helming, and S. Gordon, “Alternative activation of macrophages: an immunologic functional perspective,” Annual Review of Immunology , vol. 27, pp. 451-483, 2009 - 206.
S. Gordon and F. O. Martinez, “Alternative activation of macrophages: mechanism and functions,” Immunity , vol. 32,no. 5, pp. 593-604, 2010 - 207.
C. Jim’enez-L’opez and M. C. Lorenz, “Fungal immune evasion in a model host-pathogen interaction: Candida albicans versus macrophages,”PLoS Pathogens , vol. 9, Article IDe1003741, 2013 - 208.
O. V. Vieira, R. J. Botelho, and S. Grinstein, “Phagosome maturation: aging gracefully,” Biochemical Journal , vol. 366, no. 3, pp. 689-704, 2002 - 209.
D. M. Mosser and J. P. Edwards, “Exploring the full spectrum of macrophage activation,” Nature Reviews Immunology , vol. 8, no. 12, pp. 958-969, 2008 - 210.
M. Stein, S. Keshav, N. Harris, and S. Gordon, “Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation,” Journal of ExperimentalMedicine , vol. 176, no. 1, pp. 287-292, 1992 - 211.
M.Hesse,M.Modolell, A. C. La Flamme et al., “Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism,” Journal of Immunology , vol.167, no. 11, pp. 6533-6544, 2001 - 212.
A. Tavanti, D. Campa, A. Bertozzi et al., “ Candida albicans isolates with different genomic backgrounds display a differential response to macrophage infection,”Microbes and Infection , vol. 8, no. 3, pp. 791-800, 2006 - 213.
I. E. Frohner, C. Bourgeois, K. Yatsyk,O.Majer, andK. Kuchler, “ Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance,“MolecularMicrobiology , vol. 71,no. 1, pp. 240-252, 2009 - 214.
B. D. Ullmann, H. Myers, W. Chiranand et al., “Inducible defense mechanism against nitric oxide in Candida albicans ,”Eukaryotic Cell , vol. 3, no. 3, pp. 715-723, 2004 - 215.
E. Fern’andez-Arenas, V. Cabez’on, C. Bermejo et al., “Integrated proteomics and genomics strategies bring new insight into Candida albicans response upon macrophage interaction,”Molecular and Cellular Proteomics , vol. 6, no. 3, pp. 460-478, 2007